Novel PLGA -based nanoparticles

Conclusion: ISTPPLG6 NPs can act as potential drug carriers for the oral delivery of insulin. Read this original research and sign up to receive International Journal of Nanomedicine here: http://www.dovepress.com/articles.php?article_id=20923
8 Pins
·
9y
Figure 2 Particle size analysis of (A) ISTPPLG 4 NPs and (B) ISTPPLG 6 NPs.
Figure 3 TEM micrographs of (A) ISTPPLG 4 NPs and (B) ISTPPLG 6 NPs.
Figure 4 In vitro release profile of ISTPPLG NPs.
Figure 5 Schematic illustration of insulin release from insulin-loaded TPGS-emulsified PEG-capped PLGA nanoparticles.
Figure 6 Effect of ISTPPLG NPs on serum glucose and insulin levels in STZ-induced diabetic rats.
Figure 7 Effect of ISTPPLG 6 NPs on histopathological changes of the liver, kidney, and pancreas.
Figure 8 Schematic representation of the transport of drug-loaded polymeric nanoparticles (ISTPPLG NPs) across the intestinal epithelium.